Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload

General Thoracic and Cardiovascular Surgery

Volumn 58, Issue 6, 2010, Pages 265-270

  Tateishi, Atsushi ^a   Matsushita, Masayuki ^a   Asai, Tomohiro ^a   Masuda, Zenichi ^a   Kuriyama, Mitsuhito ^a   Kanki, Kazushige ^a   Ishino, Kozo ^a   Kawada, Masaaki ^a   Sano, Shunji ^a   Matsui, Hideki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cardiac hypertrophy; Glycogen synthase kinase 3 ; Lithium; Wnt; Catenin

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; MESSENGER RNA; PHOSPHOSERINE; BETA CATENIN; CARDIOVASCULAR AGENT; CTNNB1 PROTEIN, RAT; GLYCOGEN SYNTHASE KINASE 3 BETA; PROTEIN KINASE INHIBITOR; SERINE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CELL GROWTH; CONTROLLED STUDY; DESCENDING AORTA SURGERY; DISSOCIATION; ECHOCARDIOGRAPHY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXPERIMENTAL MODEL; GENE EXPRESSION; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HEART WEIGHT; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; WESTERN BLOTTING; ABDOMINAL AORTA; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD PRESSURE; COMPLICATION; DISEASE MODEL; ECHOGRAPHY; ENZYMOLOGY; GENETICS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LIGATION; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; SURGERY; TIME; WISTAR RAT;

ANIMALS; AORTA, ABDOMINAL; ATRIAL NATRIURETIC FACTOR; BETA CATENIN; BLOOD PRESSURE; BLOTTING, WESTERN; CARDIOVASCULAR AGENTS; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LIGATION; LITHIUM CHLORIDE; MALE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; RNA, MESSENGER; SERINE; TIME FACTORS;

EID: 77955938354     PISSN: 18636705     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11748-009-0505-2     Document Type: Article

References (12)

1. H. Akazawa I. Komuro 2003 Roles of cardiac transcription factors in cardiac hypertrophy Circ Res 92 1079 1088 10.1161/01.RES.0000072977.86706.23 1:CAS:528:DC%2BD3sXjvFarsbg%3D 12775656
2. E.N. Olson M.D. Schneider 2003 Sizing up the heart: development redux in disease Genes Dev 17 1937 1956 10.1101/gad.1110103 1:CAS:528: DC%2BD3sXms1Knsbg%3D 12893779
3. J.D. Molkentin 2004 Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs Cardiovasc Res 63 467 475 10.1016/j.cardiores.2004.01.021 1:CAS:528:DC%2BD2cXmtVWiur4%3D 15276472
4. C.L. Antos T.A. McKinsey N. Frey W. Kutschke J. McAnally J.M. Shelton, et al. 2002 Activated glycogen synthase-3beta sup-presses cardiac hypertrophy in vivo Proc Natl Acad Sci U S A 99 907 912 10.1073/pnas.231619298 1:CAS:528:DC%2BD38Xht1WisLY%3D 11782539
5. S. Haq A. Michael M. Andreucci K. Bhattacharya P. Dotto B. Walters, et al. 2003 Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth Proc Natl Acad Sci U S A 100 4610 4615 10.1073/pnas.0835895100 1:CAS:528:DC%2BD3sXjt12nsrw%3D 12668767
6. M. Brancaccio L. Fratta A. Notte E. Hirsch R. Poulet S. Guazzone, et al. 2003 Melusin, a muscle-specific integrin β1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload Nat Med 9 68 75 10.1038/nm805 1:CAS:528:DC%2BD3sXivF2r 12496958
7. S.E. Hardt H. Tomita H.A. Katus J. Sadoshima 2004 Phosphorylation of eukaryotic translation initiation factor 2B epsilon by glycogen synthase kinase-3β regulates β-adrenergic cardiac myocyte hypertrophy Circ Res 94 926 935 10.1161/01.RES.0000124977.59827.80 1:CAS:528:DC%2BD2cXivVKqtr4%3D 15001529
8. S. Haq G. Choukroun Z.B. Kang H. Ranu T. Matsui A. Rosenzweig, et al. 2000 Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy J Cell Biol 151 117 129 10.1083/jcb.151.1.117 1:CAS:528: DC%2BD3cXntFSlsbk%3D 11018058
9. M. Kuriyama M. Matsushita A. Tateishi A. Moriwaki K. Tomizawa K. Ishino, et al. 2006 A cell-permeable NFAT inhibitor peptide prevents pressure-overload cardiac hypertrophy Chem Biol Drug Des 67 238 243 10.1111/j.1747-0285.2006. 00360.x 1:CAS:528:DC%2BD28Xksleju70%3D 16611217
10. S. Hirotani P. Zhai H. Tomita J. Galeotti J.P. Marquez S. Gao, et al. 2007 Inhibition of glycogen synthase 3β during heart failure is protective Circ Res 101 1164 1174 10.1161/CIRCRESAHA.107.160614 1:CAS:528: DC%2BD2sXhtlahurjN 17901358
11. A. Baurand L. Zelarayan R. Betney C. Gehrke S. Dunger C. Noack, et al. 2007 β-Catenin downregulation is required for adaptive cardiac remodeling Circ Res 100 1353 1362 10.1161/01.RES.0000266605.63681.5a 1:CAS:528: DC%2BD2sXkvVOgsLY%3D 17413044
12. A. Michael S. Haq X. Chen E. Hsich L. Cui B. Walters, et al. 2004 Glycogen synthase kinase-3β regulates growth, calcium homeostasis, and diastolic functions in the heart J Biol Chem 279 21383 21393 10.1074/jbc.M401413200 1:CAS:528:DC%2BD2cXjvV2nurY%3D 15020584